每年春节，旅游市场都会上演一场供需大戏。 2026马年春节尤其热闹：出境游回暖、国内游火爆，而最让游客直呼"吃不消"的，莫过于住宿价格一路 狂飙。 潮汕、泉州等新晋顶流文旅城市，酒店价格直接冲上热搜：平日两三百元的快捷酒店，春节轻松破千； 核心景区、商圈附近，一晚两三千元已是常态。 一边是游客吐槽"住不起"，一边是酒店满房、民宿涨价、平台一房难求。这场春节酒店涨价潮，到底是 市场规律，还是过度炒作？背后藏着怎样的消费逻辑与行业真相？ 结合近期平台预订数据与游客实际反馈，春节假期潮汕、泉州等地住宿价格呈现三大特征，涨幅普遍较 大；平日200—300元的经济型酒店，春节直接涨到800—1500元； 中端酒店普遍站上1000—2000元，部分位置好的民宿、精品酒店直逼2500元以上。 2月10日晚间21世纪经济报道记者从OTA平台上搜索除夕当天到2月19日开始的汕头和泉州等地连锁价格 酒店均呈现出一定程度的上涨，众多经济型和中端酒店价格都飙升至千元。 商务大床房 (2) 1张1.8米大床 2人入住 25-29㎡ 2份早餐 入住当天18:00前可免费取消 > 立即确认 ¥1445 均¥1.57 无早餐 \ \ 立即确 ...

Core Insights - Major international beer companies are revealing their financial results, indicating a trend of slowing growth and declining sales [2][4] Group 1: Heineken Group - Heineken reported a net revenue of €28.753 billion for 2025, with a net profit of €1.885 billion, both showing a decline for two consecutive years [2] - The company has lowered its growth expectations for 2026 and plans to save €400-500 million, including layoffs of 5,000 to 6,000 employees [2][10] - Heineken's overall performance showed a decline in sales revenue, operating profit, and volume, with a 4.7% drop in revenue and a 1.2% decrease in volume for 2025 [5][6] - Despite the overall decline, Heineken achieved double-digit growth in 27 markets and emphasized maintaining or increasing market share in over 60% of its markets [7][6] - In China, Heineken's sales continued to grow, with significant contributions from its local partner, China Resources Beer [8] Group 2: Budweiser APAC - Budweiser APAC reported a revenue of $5.764 billion for 2025, with a 6.1% year-on-year decline in organic revenue and a 9.8% drop in normalized EBITDA [2][12] - The company faced significant challenges, with net profit dropping over 32% to $489 million, marking a new low since its listing [2][12] - In China, Budweiser's revenue fell by 11.3%, with a 15.7% decline in normalized EBITDA and an 8.6% drop in volume for 2025 [14][16] - Budweiser aims to restore growth in China, focusing on enhancing its product mix and increasing investment in non-immediate consumption channels [18][16]

21世纪经济报道记者唐唯珂 每年春节，旅游市场都会上演一场供需大戏。 2026马年春节尤其热闹：出境游回暖、国内游火爆，而最让游客直呼"吃不消"的，莫过于住宿价格一路 狂飙。 潮汕、泉州等新晋顶流文旅城市，酒店价格直接冲上热搜：平日两三百元的快捷酒店，春节轻松破千； 核心景区、商圈附近，一晚两三千元已是常态。 一边是游客吐槽"住不起"，一边是酒店满房、民宿涨价、平台一房难求。这场春节酒店涨价潮，到底是 市场规律，还是过度炒作？背后藏着怎样的消费逻辑与行业真相？ 结合近期平台预订数据与游客实际反馈，春节假期潮汕、泉州等地住宿价格呈现三大特征，涨幅普遍较 大；平日200—300元的经济型酒店，春节直接涨到800—1500元； 中端酒店普遍站上1000—2000元，部分位置好的民宿、精品酒店直逼2500元以上。 2月10日晚间21世纪经济报道记者从OTA平台上搜索除夕当天到2月19日开始的汕头和泉州等地连锁价格 酒店均呈现出一定程度的上涨，众多经济型和中端酒店价格都飙升至千元。 1张1.8米大床 2人入住 25-29㎡ 2份早餐 入住当天18:00前可免费取消 > 立即确认 r 20 6 均 1579 优惠116 ...

Group 1 - Chinese home appliance companies are establishing significant manufacturing bases in Thailand, with major players like Hisense, Haier, TCL, and Midea leading the charge [1] - Hisense's HHA smart manufacturing industrial park is set to be the largest overseas production base for the company, while Haier's air conditioning industrial park in Thailand is the largest for Chinese brands in Southeast Asia [1] - The construction of these factories is characterized by rapid development, with Haier's facility being completed in just nine months, showcasing industry-leading construction speed [1] Group 2 - Chinese home appliances are increasingly preferred in Thailand, previously dominated by Japanese and Korean brands, due to their competitive pricing and advanced technology [2] - The core competitive advantages of Chinese appliances include tailored product designs that meet local needs, efficient cost management through supply chain optimization, and innovative marketing strategies [2] - Thailand serves as a key observation point for how Chinese home appliance companies can successfully establish a strong market presence in foreign territories [2]

Group 1 - The core point of the article is the establishment of Guanghe Tong Embodied Intelligent Technology (Suzhou) Co., Ltd., which is fully owned by Guanghe Tong (300638) and has a registered capital of 30 million RMB [1][2][3] - The company’s business scope includes research and development of intelligent robots, sales of intelligent robots, sales of artificial intelligence hardware, manufacturing of service consumer robots, and development of various artificial intelligence software [1][2] - The legal representative of the company is Ying Lingpeng, and it is registered under the Suzhou Industrial Park Administrative Approval Bureau [2][3] Group 2 - The company is classified as a limited liability company with a focus on software development and artificial intelligence applications [2][3] - The company is part of the National Small and Medium-sized Enterprise Development Fund, indicating potential support and resources from government initiatives [2][3] - The business operations are set to continue indefinitely, with no fixed expiration date for the business license [2]

Group 1 - The three major indices collectively rose, with the Shanghai Stock Exchange Science and Technology Innovation Board Composite Index increasing by 1.33% as of the report time [1] - Among the constituent stocks of the index, Youke De and Science & Technology reached the daily limit, while Oulain New Materials surged over 16% [1] - The Tianhong ETF tracking the Science and Technology Innovation Index had a trading volume exceeding 17 million yuan, with a turnover rate of over 6%, indicating active trading [1] Group 2 - The Science and Technology Innovation Index ETF closely tracks the Science and Technology Innovation Index, covering approximately 97% of the market capitalization of the Science and Technology Innovation Board, with a focus on small-cap hard technology companies [1] - The top ten weighted stocks in the index include leading technology firms such as Cambrian, Haiguang Information, and SMIC [1] - A new AI application scenario open platform, LuckyMate.AI, was launched in Huaqiangbei, Shenzhen, aimed at providing sustainable solutions for "Artificial Intelligence +" scenarios [1] Group 3 - According to Caixin Securities, historical market data suggests that the relative profit growth of "technology and value" has not reversed, and the differentiation in growth and value valuation is not extreme [1] - The overall trading congestion in the TMT sector remains low, leading to expectations that the market style may return to a "technology growth" focus in the medium term [1]

Core Viewpoint - The recent launch of GLM-5 by Zhiyu has significantly boosted its stock price, with a 24.84% increase on February 12 and an overall rise of over 70% for the week, driven by its advanced capabilities in coding and agent tasks [2]. Group 1: Product Features and Performance - GLM-5 has achieved state-of-the-art (SOTA) performance in coding and agent capabilities, aligning closely with Claude Opus 4.5 in real programming scenarios [2]. - The model ranks fourth globally and first among open-source models on the authoritative Artificial Analysis leaderboard [2]. - GLM-5's parameter scale has expanded from 355 billion (with 32 billion activated) to 744 billion (with 40 billion activated), and pre-training data has increased from 23 terabytes to 28.5 terabytes, enhancing its general intelligence level [5]. - The introduction of asynchronous reinforcement learning and the "Slime" framework allows for larger model scales and more complex tasks, improving training efficiency [5]. - The integration of DeepSeek Sparse Attention significantly reduces deployment costs while maintaining long text performance, enhancing token efficiency [5]. Group 2: Application and Integration - GLM-5 supports end-to-end application development, with developers creating various applications such as puzzle games and interactive agent worlds, which are now available for download or under review [5]. - The model can convert text or materials directly into .docx, .pdf, and .xlsx files, facilitating the generation of various documents like product requirement documents and financial reports [6]. - GLM-5 has been deeply optimized for major domestic chip platforms, ensuring high throughput and low latency on domestic computing clusters [4]. - The model is now open-sourced on platforms like Hugging Face and ModelScope, increasing accessibility for developers [7].

Group 1 - The article discusses the upcoming Spring Festival holiday and encourages individuals to consider investing their idle funds instead of leaving them in bank accounts [1] - It highlights the importance of financial planning and investment strategies during the holiday season to maximize returns [1] - The piece suggests various investment options that could be considered for those looking to utilize their spare cash effectively [1]

Market Overview - The Hong Kong stock market experienced a downward trend in the morning session, with the Hang Seng Index falling by 0.89% and the Hang Seng Tech Index declining by 1.68% [1] Sector Performance - The AI application sector showed strong performance, with notable gains: Zhiyun surged nearly 25%, MINIMAX-WP increased over 14%, and Kingsoft Cloud rose more than 4% [1] - The electric equipment sector continued its upward momentum, highlighted by Dongfang Electric rising over 11%, Harbin Electric increasing more than 7%, and Flat Glass Group gaining over 2% [1] - The optical communication sector was active, with Yangtze Optical Fiber and Cable rising over 11%, Huiju Technology increasing more than 7%, and Cambridge Technology gaining over 2% [1] - The pharmaceutical sector exhibited mixed results, with Reborn Bio rising by 13.65%, WuXi Biologics increasing by 4.83%, and Baidu's biotech unit rising by 3.88%, while three other companies saw declines [1] Capital Flow - Southbound capital saw a net inflow of nearly 2.8 billion HKD in the morning session [1]

Core Viewpoint - After a decade of collaboration in the insulin sector, China Resources has decided to divest from Tianmai Biotech, indicating a strategic shift towards focusing on core business operations and asset optimization [1][3]. Company Summary - China Resources Pharmaceutical announced plans to publicly transfer approximately 17.87% of its stake in Tianmai Biotech, with a base price of around 1.42 billion yuan, valuing Tianmai at approximately 8 billion yuan [1][3]. - Following this transaction, China Resources' stake will decrease from 20% to 5.88%, effectively ending its position as the largest shareholder [3]. - The partnership began in 2016 during a period of growth in the domestic insulin market, with China Resources investing in Tianmai due to its technological capabilities in recombinant human insulin [5][6]. - Tianmai Biotech has faced setbacks, particularly with its oral insulin product, which failed to gain regulatory approval, impacting its competitive edge and leading to a reevaluation of its future prospects by China Resources [6][9]. Industry Summary - The insulin market in China has become increasingly competitive, with price reductions due to centralized procurement policies and the emergence of local leaders like Ganli Pharmaceutical and Tonghua Dongbao [8]. - The failure of Tianmai's oral insulin product has raised concerns about its product pipeline and growth potential, making it difficult for the company to align with China Resources' core business focus [7][9]. - The divestment reflects broader challenges faced by domestic biotech firms in maintaining capital support and commercial viability amidst high investment risks in innovative drug development [9].